{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:58:56Z","timestamp":1784257136092,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"DOI":"10.7759\/cureus.35638","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T12:32:15Z","timestamp":1677673935000},"source":"Crossref","is-referenced-by-count":4,"title":["Continuous Ketamine Infusion as a Treatment for Refractory Facial Pain"],"prefix":"10.7759","author":[{"given":"Roxana","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QiLiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Posadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000927","article-title":"Facial pain beyond trigeminal neuralgia","volume":"34","author":"May A","year":"2021","unstructured":"May A, Hoffmann J. Facial pain beyond trigeminal neuralgia. Curr Opin Neurol. 2021, 34:373-7. 10.1097\/WCO.0000000000000927","journal-title":"Curr Opin Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joen.2020.12.002","article-title":"New International Classification of orofacial pain: what is in it for endodontists?","volume":"47","author":"Pigg M","year":"2021","unstructured":"Pigg M, Nixdorf DR, Law AS, Renton T, Sharav Y, Baad-Hansen L, List T. New International Classification of orofacial pain: what is in it for endodontists?. J Endod. 2021, 47:345-57. 10.1016\/j.joen.2020.12.002","journal-title":"J Endod"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30233-7","article-title":"Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia","volume":"19","author":"Bendtsen L","year":"2020","unstructured":"Bendtsen L, Zakrzewska JM, Heinskou TB, et al.. Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurol. 2020, 19:784-96. 10.1016\/S1474-4422(20)30233-7","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17197012","article-title":"Chronic facial pain: trigeminal neuralgia, persistent idiopathic facial pain, and myofascial pain syndrome-an evidence-based narrative review and etiological hypothesis","volume":"17","author":"Gerwin R","year":"2020","unstructured":"Gerwin R. Chronic facial pain: trigeminal neuralgia, persistent idiopathic facial pain, and myofascial pain syndrome-an evidence-based narrative review and etiological hypothesis. Int J Environ Res Public Health. 2020, 17:7012. 10.3390\/ijerph17197012","journal-title":"Int J Environ Res Public Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/head.14212","article-title":"Characteristics and natural disease history of persistent idiopathic facial pain, trigeminal neuralgia, and neuropathic facial pain","volume":"61","author":"Ziegeler C","year":"2021","unstructured":"Ziegeler C, Brauns G, May A. Characteristics and natural disease history of persistent idiopathic facial pain, trigeminal neuralgia, and neuropathic facial pain. Headache. 2021, 61:1441-51. 10.1111\/head.14212","journal-title":"Headache"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002126","article-title":"Altered trigeminal pain processing on brainstem level in persistent idiopathic facial pain","volume":"162","author":"Ziegeler C","year":"2021","unstructured":"Ziegeler C, Schulte LH, May A. Altered trigeminal pain processing on brainstem level in persistent idiopathic facial pain. Pain. 2021, 162:1374-8. 10.1097\/j.pain.0000000000002126","journal-title":"Pain"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000277274.83301.c0","article-title":"Differences and similarities between atypical facial pain and trigeminal neuropathic pain","volume":"69","author":"Forssell H","year":"2007","unstructured":"Forssell H, Tenovuo O, Silvoniemi P, J\u00e4\u00e4skel\u00e4inen SK. Differences and similarities between atypical facial pain and trigeminal neuropathic pain. Neurology. 2007, 69:1451-9. 10.1212\/01.wnl.0000277274.83301.c0","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18910","article-title":"Use of ketamine infusions for treatment of complex regional pain syndrome: a systematic review","volume":"13","author":"Chitneni A","year":"2021","unstructured":"Chitneni A, Patil A, Dalal S, Ghorayeb JH, Pham YN, Grigoropoulos G. Use of ketamine infusions for treatment of complex regional pain syndrome: a systematic review. Cureus. 2021, 13:e18910. 10.7759\/cureus.18910","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000004185","article-title":"Ketamine infusions for chronic pain: a systematic review and meta-analysis of randomized controlled trials","volume":"129","author":"Orhurhu V","year":"2019","unstructured":"Orhurhu V, Orhurhu MS, Bhatia A, Cohen SP. Ketamine infusions for chronic pain: a systematic review and meta-analysis of randomized controlled trials. Anesth Analg. 2019, 129:241-54. 10.1213\/ANE.0000000000004185","journal-title":"Anesth Analg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2008.06.006","article-title":"Ketamine, not fentanyl, suppresses pain-related magnetic fields associated with trigeminally innervated area following CO2 laser stimulation","volume":"62","author":"Matsuura N","year":"2008","unstructured":"Matsuura N, Shibukawa Y, Kato M, Ichinohe T, Suzuki T, Kaneko Y. Ketamine, not fentanyl, suppresses pain-related magnetic fields associated with trigeminally innervated area following CO2 laser stimulation. Neurosci Res. 2008, 62:105-11. 10.1016\/j.neures.2008.06.006","journal-title":"Neurosci Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001545","article-title":"Plasticity in the dynamic pain connectome associated with ketamine-induced neuropathic pain relief","volume":"160","author":"Rogachov A","year":"2019","unstructured":"Rogachov A, Bhatia A, Cheng JC, et al.. Plasticity in the dynamic pain connectome associated with ketamine-induced neuropathic pain relief. Pain. 2019, 160:1670-9. 10.1097\/j.pain.0000000000001545","journal-title":"Pain"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(94)00170-J","article-title":"Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain","volume":"61","author":"Mathisen LC","year":"1995","unstructured":"Mathisen LC, Skjelbred P, Skoglund LA, \u00d8ye I. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain. 1995, 61:215-20. 10.1016\/0304-3959(94)00170-J","journal-title":"Pain"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6148.1000746","article-title":"Comparative study between intravenous ketamine and lidocaine infusion in controlling of refractory trigeminal neuralgia","volume":"8","author":"Mogahed MM","year":"2017","unstructured":"Mogahed MM, Anwar AG, Mohamed RM. Comparative study between intravenous ketamine and lidocaine infusion in controlling of refractory trigeminal neuralgia. J Anesth Clin Res. 2017, 8:8. 10.4172\/2155-6148.1000746","journal-title":"J Anesth Clin Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/eujp.2001.0232","article-title":"Interindividual differences in the analgesic response to ketamine in chronic orofacial pain","volume":"5","author":"Rabben T","year":"2001","unstructured":"Rabben T, \u00d8ye I. Interindividual differences in the analgesic response to ketamine in chronic orofacial pain. Eur J Pain. 2001, 5:233-40. 10.1053\/eujp.2001.0232","journal-title":"Eur J Pain"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.842082","article-title":"Intravenous lidocaine and ketamine infusions for headache disorders: a retrospective cohort study","volume":"13","author":"Ray JC","year":"2022","unstructured":"Ray JC, Cheng S, Tsan K, Hussain H, Stark RJ, Matharu MS, Hutton E. Intravenous lidocaine and ketamine infusions for headache disorders: a retrospective cohort study. Front Neurol. 2022, 13:842082. 10.3389\/fneur.2022.842082","journal-title":"Front Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin RH","year":"2008","unstructured":"Dworkin RH, Turk DC, Wyrwich KW, et al.. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008, 9:105-21. 10.1016\/j.jpain.2007.09.005","journal-title":"J Pain"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnab163","article-title":"Intravenous ketamine for cancer pain management, including flares during the COVID-19 pandemic: a retrospective study","volume":"22","author":"Oh D","year":"2021","unstructured":"Oh D, Haffey P, Patel A, Gulati A. Intravenous ketamine for cancer pain management, including flares during the COVID-19 pandemic: a retrospective study. Pain Med. 2021, 22:1642-50. 10.1093\/pm\/pnab163","journal-title":"Pain Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2017.197","article-title":"Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease","volume":"83","author":"Nobrega R","year":"2018","unstructured":"Nobrega R, Sheehy KA, Lippold C, Rice AL, Finkel JC, Quezado ZM. Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease. Pediatr Res. 2018, 83:445-54. 10.1038\/pr.2017.197","journal-title":"Pediatr Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000808","article-title":"Consensus Guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists","volume":"43","author":"Cohen SP","year":"2018","unstructured":"Cohen SP, Bhatia A, Buvanendran A, et al.. Consensus Guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018, 43:521-46. 10.1097\/AAP.0000000000000808","journal-title":"Reg Anesth Pain Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000633","article-title":"Multicenter retrospective review of ketamine use in the ICU","volume":"4","author":"Groth CM","year":"2022","unstructured":"Groth CM, Droege CA, Connor KA, et al.. Multicenter retrospective review of ketamine use in the ICU. Crit Care Explor. 2022, 4:e0633. 10.1097\/CCE.0000000000000633","journal-title":"Crit Care Explor"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-05939-z","article-title":"Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression","volume":"238","author":"Pennybaker S","year":"2021","unstructured":"Pennybaker S, Roach BJ, Fryer SL, Badathala A, Wallace AW, Mathalon DH, Marton TF. Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression. Psychopharmacology (Berl). 2021, 238:3229-37. 10.1007\/s00213-021-05939-z","journal-title":"Psychopharmacology (Berl)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03576.x","article-title":"Ketamine use: a review","volume":"107","author":"Morgan CJ","year":"2012","unstructured":"Morgan CJ, Curran HV. Ketamine use: a review. Addiction. 2012, 107:27-38. 10.1111\/j.1360-0443.2011.03576.x","journal-title":"Addiction"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000674","article-title":"Ketamine for pain management","volume":"3","author":"Bell RF","year":"2018","unstructured":"Bell RF, Kalso EA. Ketamine for pain management. Pain Rep. 2018, 3:e674. 10.1097\/PR9.0000000000000674","journal-title":"Pain Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2016.05.016","article-title":"Ketamine abuse potential and use disorder","volume":"126","author":"Liu Y","year":"2016","unstructured":"Liu Y, Lin D, Wu B, Zhou W. Ketamine abuse potential and use disorder. Brain Res Bull. 2016, 126:68-73. 10.1016\/j.brainresbull.2016.05.016","journal-title":"Brain Res Bull"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2018.09.001","article-title":"On the safety of repeated ketamine infusions for the treatment of depression: effects of sex and developmental periods","volume":"9","author":"Strong CE","year":"2018","unstructured":"Strong CE, Kabbaj M. On the safety of repeated ketamine infusions for the treatment of depression: effects of sex and developmental periods. Neurobiol Stress. 2018, 9:166-75. 10.1016\/j.ynstr.2018.09.001","journal-title":"Neurobiol Stress"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165461","article-title":"The effects of low-dose ketamine on acute pain in an emergency setting: a systematic review and meta-analysis","volume":"11","author":"Lee EN","year":"2016","unstructured":"Lee EN, Lee JH. The effects of low-dose ketamine on acute pain in an emergency setting: a systematic review and meta-analysis. PLoS One. 2016, 11:e0165461. 10.1371\/journal.pone.0165461","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/139652-continuous-ketamine-infusion-as-a-treatment-for-refractory-facial-pain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:46Z","timestamp":1707508786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/139652-continuous-ketamine-infusion-as-a-treatment-for-refractory-facial-pain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.35638","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}